Gordon syndrome, also known as distal arthrogryposis type 3, is a rare congenital genetic disorder that affects the movement of certain joints in the arms and legs. It is characterized by stiffness and impaired mobility of the joint.
Gordon syndrome is caused by a genetic mutation in the PIEZO2 gene. This gene influences the formation of proteins that play an important role in controlling the sensations of touch, pain, vibration, and muscle coordination. As a result, the mutation of this gene can affect mobility.
The symptoms of Gordon syndrome vary among individuals and are mostly seen in infants. They include:
Females and males are equally affected, although females tend to have less severe symptoms.
Diagnosis is done at the time of birth based on physical examination and diagnostic tests such as:
Treatment is directed towards the resolution of symptoms and includes:
People diagnosed with Gordon syndrome tend to have reduced mobility; however, with adequate treatment, the condition can be managed to prevent any negative long-term impacts on health.